The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of a patient and family meeting program for patients with metastatic genitourinary cancer receiving treatment in the ambulatory care setting.
 
Michele Stayer Ochoa
No Relationships to Disclose
 
Stefanie Mooney
Employment - City of Hope; Xencor Antibodies by Design (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb (I); CytomX Therapeutics (I); Nektar (I); OncoSec (I); Sage Therapeutics (I); Xencor (I)
 
Cristiane Decat Bergerot
No Relationships to Disclose
 
Kathleen Burns
No Relationships to Disclose
 
Finly Zachariah
No Relationships to Disclose
 
Rupinder Kaur Sidhu
No Relationships to Disclose
 
Jill Prudhomme-Hunter
No Relationships to Disclose
 
Nellie Garcia
No Relationships to Disclose
 
Sorin Buga
No Relationships to Disclose
 
William Dale
No Relationships to Disclose
 
Matthew J. Loscalzo
Employment - Puma Biotechnology (I)
Honoraria - Puma Biotechnology (I)
Patents, Royalties, Other Intellectual Property - SupportScreen royalties via my employer City of Hope (non profit)
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation